BioCryst Pharmaceuticals BCRX Changes in unrecognized tax benefits
Changes in unrecognized tax benefits at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxContingencies.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's changes in unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's changes in unrecognized tax benefits?
- BioCryst Pharmaceuticals (BCRX) reported changes in unrecognized tax benefits of -$54.25K in Q4 2025.
- How has BioCryst Pharmaceuticals's changes in unrecognized tax benefits changed year-over-year?
- BioCryst Pharmaceuticals's changes in unrecognized tax benefits decreased by 161.5% year-over-year, from $88.25K to -$54.25K.
- What is the long-term trend for BioCryst Pharmaceuticals's changes in unrecognized tax benefits?
- Over 2 years (2023 to 2025), BioCryst Pharmaceuticals's changes in unrecognized tax benefits has grown at a -48.7% compound annual growth rate (CAGR), from $825K to -$217K.
- What does changes in unrecognized tax benefits mean?
- Reflects the financial impact of uncertain tax positions, including reserves for potential tax audits or disputes with taxing authorities. It represents the estimated liability for tax positions that may not be sustained upon examination.